HLX-Reta: Triple Agonist Peptide (Research Use Only)
Multi-Receptor Peptide for Advanced Metabolic Research
Experience innovation in metabolic science with Triple Agonist Peptide, a groundbreaking triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. This next-generation research compound is designed to explore mechanisms behind weight regulation, glucose control, and energy balance — offering a powerful tool for studies in obesity, diabetes, and metabolic health.
Product Details:
-
Name: Triple Agonist Peptide
-
Quantity: 10mg (Lyophilized Powder)
-
Molecular Formula: C187H291N51O58
-
Molecular Weight: 4187.67 g/mol
-
Purity: ≥99% (Third-Party Tested via HPLC & MS)
-
Appearance: White to off-white lyophilized powder
-
Storage: Store refrigerated at 2°C–8°C, protected from light and moisture
Research Highlights:
-
Investigated for enhanced insulin sensitivity and improved glucose metabolism
-
Shown in studies to promote fat loss and lean body mass retention
-
Activates multiple metabolic pathways for superior energy balance
-
Valuable for research into obesity, type 2 diabetes, and liver health
Note:
For research purposes only. Not for human consumption.
Unlock the potential Triple Agonist Peptide of with Helixion Labs — where precision, purity, and performance drive scientific discovery.